Data Characteristics
Preclinical safety pharmacology data originates from animal study reports, in-vitro research, and early toxicology studies. This data typically combines structured formats (e.g., preclinical study databases, electronic lab notebooks) and unstructured formats (e.g., detailed research reports in PDF, pathology slide descriptions). Updates occur in batches, usually after each experimental phase. Document structures vary, potentially including experimental designs, animal grouping, dosing regimens, observation metrics (weight, physiological and biochemical indicators, pathological findings), and statistical analysis results. Fields include dosage (e.g., mg/kg), administration route, observation time points (e.g., h, d, w), organ weights (g, mg), and pathological scores (0-5 levels). Units are largely standardized, but descriptive text may contain synonyms or abbreviations.
Constraints Imposed by Data Characteristics on Workflow Orchestration
The mixed structure of preclinical safety pharmacology data challenges information extraction nodes within a workflow. Unstructured reports require advanced natural language processing to identify key information, such as adverse events and dose-toxicity relationships. Batch data updates mean workflows are not suited for high-frequency, real-time triggers. Instead, scheduled or event-driven batch processing is more appropriate. Diverse fields and units necessitate robust rule engines and unit conversion capabilities in data cleaning and standardization modules to ensure data consistency. Data involves animal ethics and research compliance, so workflows must integrate audit logs. These logs record each data processing step and ensure data traceability. When processing historical data, workflows may encounter evolving data formats, requiring version compatibility handling.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Segment Length) | 500-800 characters | Balances semantic completeness and model processing efficiency, preventing key information from being split. |
Recall count (Retrieval Count) | Top 10 | Ensures retrieval of sufficient relevant document segments, covering potential adverse event information. |
Similarity threshold (Similarity Threshold) | 0.75-0.85 | Balances recall and precision, filtering out irrelevant experimental records. |
Rerank result count (Reranked Retrieval Count) | Top 5 | Further refines results, prioritizing the most relevant toxicology data. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Accommodates longer parsing times for large PDF experimental reports, preventing timeout. |
maxContext | 4000 tokens | Ensures the model has sufficient context to understand adverse event correlations. |
Common Pitfalls
- A workflow node executes without output, with logs showing "no running result." This often indicates that external environment variables required by the node's internal code are not configured correctly, or necessary libraries are missing from the container environment.
- Knowledge base queries return empty results, preventing the large language model from generating effective responses. This usually happens because the knowledge base index is not built or the query statement's match with document content is too low.
- Chart tools generate blank charts. The tool triggers, but the chart does not render. This usually means the data format returned by the tool's API does not match the chart component's expectations, or data field names do not align with the configuration.
Verification Steps
- Upload a typical preclinical safety pharmacology PDF report. Check if the knowledge base correctly extracts and indexes key fields like
animal grouping,dosage, andmain toxic reactions. - Execute the workflow for a simulated query scenario, such as "liver toxicity performance of compound X in canine studies." Verify that the retrieved document segments accurately contain relevant research results.
- Integrate a data visualization node into the workflow. Input dose-effect data extracted from safety pharmacology reports. Check if the chart correctly generates and displays the dose-response relationship.
The values provided are common starting points and should be measured against specific samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.